Lv1
58 积分 2022-07-06 加入
Therapeutic targeting of the p300/CBP bromodomain enhances the efficacy of immune checkpoint blockade therapy
8小时前
已完结
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
1个月前
已完结
Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate Cancer
1个月前
已完结
Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma
2个月前
已完结
Prostate cancer: BETting on epigenetic therapy
2个月前
已关闭
Studies on Steroid Receptor Coactivators in Prostate Cancer
2个月前
已完结
Bifunctional proximity-inducing strategies for targeted and programmable post-translational modifications
2个月前
已完结
Discovery of Cdc20/Hsp90 Dual-Target Inhibitors with Potent Antitumor Activity for Therapy of Acquired Resistant Melanoma
2个月前
已完结
Discovery of ZX079 as a Dual PROTAC Degrader Targeting BRD4/CBP in Acute Myeloid Leukemia
2个月前
已完结
Inflammation-Driven Transcriptional Reprogramming in Prostate Cancer: Convergence of NFκB, JAK/STAT3, and Epigenetic Remodeling in Castration-Resistant Disease
2个月前
已完结
皖公网安备34019202002308
